Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials for Cancer in United States

7944 results

Sort By:

Obinutuzumab and ICE Chemotherapy in Refractory/Recurrent CD20+ Mature NHL

Study ID: NCT02393157
Start Date: 2015-08-21
End Date: 2024-12
Study Type

Interventional

Study Phase

Phase2

No. of Participants

25

Intervention / Treatment

Obinutuzumab

Liposomal ARA-C

Ifosfamide

Carboplatin

Etoposide

Sponsor

New York Medical College

Source: clinicaltrials.gov

Share:
Add to list

PhI/II Study of Amivantamab and Tepotinib Combo in MET-altered Non-small Cell Lung Cancer

Study ID: NCT06083857
Start Date: 2024-06-18
End Date: 2027-12-31
Study Type

Interventional

Study Phase

Phase2

No. of Participants

60

Intervention / Treatment

Amivantamab

Tepotinib

Sponsor

M.D. Anderson Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

Preserving Physical Function in Older Adults With Cancer: Impact of an Optimizing Nutrition Intervention Applied Before and After Surgery

Study ID: NCT05912257
Start Date: 2024-05-01
End Date: 2027-06-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

188

Intervention / Treatment

Structured perioperative nutrition and exercise

Nutrition and Exercise Counseling

Sponsor

VA Office of Research and Development

Source: clinicaltrials.gov

Share:
Add to list

Jump: MR Simulation For Radiation Therapy Master Protocol

Study ID: NCT04545957
Start Date: 2020-10-14
End Date: 2026-10-22
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

86

Intervention / Treatment

MRI Simulator

Radiation Therapy

Sponsor

Dana-Farber Cancer Institute

Source: clinicaltrials.gov

Share:
Add to list

Safety and Tolerability Study of GIM-531 in Advanced Solid Tumors

Study ID: NCT06425926
Start Date: 2024-05-09
End Date: 2026-11
Study Type

Interventional

Study Phase

Phase2

No. of Participants

117

Intervention / Treatment

GIM-531

Anti-PD-1 monoclonal antibody

Sponsor

Georgiamune Inc

Source: clinicaltrials.gov

Share:
Add to list

First in Human Study of TORL-3-600 in Participants With Advanced Cancer

Study ID: NCT05948826
Start Date: 2023-09-29
End Date: 2026-09-15
Study Type

Interventional

Study Phase

Phase1

No. of Participants

70

Intervention / Treatment

TORL-3-600

Sponsor

TORL Biotherapeutics, LLC

Source: clinicaltrials.gov

Share:
Add to list

A Study of NVL-655 in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)

Study ID: NCT05384626
Start Date: 2022-06-09
End Date: 2026-03
Study Type

Interventional

Study Phase

Phase2

No. of Participants

470

Intervention / Treatment

NVL-655

Sponsor

Nuwalnt Inch.

Source: clinicaltrials.gov

Share:
Add to list

Lifestyle Medicine: Establishing Clinical Approaches to Chronic Disease for Rural Patients

Study ID: NCT06049420
Start Date: 2024-04
End Date: 2025-09
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

95

Intervention / Treatment

Lifestyle counseling and coaching

Sponsor

West Virginia School of Osteopathic Medicine

Source: clinicaltrials.gov

Share:
Add to list

Targeted Therapy With CDK4/6 Inhibitors in Chemo-Refractory, Rb Wild-Type Extensive SCLC

Study ID: NCT04010357
Start Date: 2020-01-13
End Date: 2025-06
Study Type

Interventional

Study Phase

Phase2

No. of Participants

29

Intervention / Treatment

Abemaciclib,

Sponsor

Case Comprehensive Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

Trial of 225Ac-DOTATATE (RYZ101) in Subjects with ER+, HER2-negative Unresectable or Metastatic Breast Cancer Expressing SSTRs.

Study ID: NCT06590857
Start Date: 2024-07-19
End Date: 2033-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

124

Intervention / Treatment

Ryz101

Sponsor

RayzeBio, Inc.

Source: clinicaltrials.gov

Share:
Add to list